Lv1
94 积分 2023-12-22 加入
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
1天前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
2天前
已完结
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
2天前
已完结
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
3天前
已完结
Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies
3天前
已完结
Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis
10天前
已完结
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study
14天前
已完结
Biologic Therapies for Severe Asthma
15天前
已完结
Biologic Therapies for Severe Asthma
15天前
已完结
Sequential antigen loss and branching evolution in lymphoma after CD19- and CD20-targeted T-cell–redirecting therapy
16天前
已完结
皖公网安备34019202002308
